Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 5/2022

01-05-2022 | Computed Tomography | Original Article – Clinical Oncology

Overuse of follow-up chest computed tomography in patients with incidentally identified nodules suspicious for lung cancer

Authors: Ran Guo, Yang Zhang, Zelin Ma, Chaoqiang Deng, Fangqiu Fu, Hong Hu, Yihua Sun, Haiquan Chen

Published in: Journal of Cancer Research and Clinical Oncology | Issue 5/2022

Login to get access

Abstract

Purpose

Although professional societies agreed that CT screening inconsistent with recommendation leads to radiation-related cancer and unexpected cost, many patients still undergo unnecessary Chest CT before treatment. The goal of this study was to assess the overuse of Chest CT in different type of patients.

Methods

Data on 1853 patients who underwent pulmonary resection from May 2019 to May 2020 were retrospectively analyzed. Data collected include age, sex, follow-up period, density and size of nodules and frequency of undergoing Chest CT. Pearson χ2 test and logistic regression were conducted to compare the receipt of CT screening.

Results

Among 1853 patients in the study, 689 (37.2%) overused Chest CT during follow-up of the pulmonary nodules. This rate was 16.2% among patients with solid nodules, 57.5% among patients with pure ground glass opacity (pGGO), and 41.4% among patients with mixed ground glass opacity (mGGO) (P < 0.001). 50.7% in the “age ≤ 40” group, 39.8% in the “41 ≤ age ≤ 50” group, 38.7% in the “51 ≤ age ≤ 60” group, 32.3% in the “61 ≤ age ≤ 70” group, 27.8% in the “ > 70” group underwent unnecessary CT (P < 0.001). Female got more unnecessary CT than male (40.6% vs 32.8%, P < 0.001). Factors associated with a greater likelihood of overusing Chest CT was the density of nodules [odds ratios (ORs) of 0.53 for mGGO; 0.15 for solid nodule, P < 0.0001, vs patients with pGGO].

Conclusion

Roughly 37% patients with pulmonary nodules received Chest CT too frequently despite national recommendations against the practice. Closer adherence to clinical guidelines is likely to result in more cost-effective care.
Literature
go back to reference Board on Radiation Effects Research, Division on Earth and Life Studies, National Research Council of the National Academies (2005) Health risks from exposure to low levels of ionizing radiation. BEIR VII, Phase 2. National Academies Press, Washington, DC Board on Radiation Effects Research, Division on Earth and Life Studies, National Research Council of the National Academies (2005) Health risks from exposure to low levels of ionizing radiation. BEIR VII, Phase 2. National Academies Press, Washington, DC
go back to reference Ettinger DS, Argiris A, Bepler G. NCCN Clinical practice guidelines in oncology: non–small cell lung cancer. Version 1.2004. Obtained with permission from NCCN February 2, 2019. To view the most recent version, visit NCCN.org Ettinger DS, Argiris A, Bepler G. NCCN Clinical practice guidelines in oncology: non–small cell lung cancer. Version 1.2004. Obtained with permission from NCCN February 2, 2019. To view the most recent version, visit NCCN.org
go back to reference International Agency for Research on Cancer, World Health Organization (2013) Lung cancer. In: GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer, World Health Organization, Lyon, France International Agency for Research on Cancer, World Health Organization (2013) Lung cancer. In: GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. International Agency for Research on Cancer, World Health Organization, Lyon, France
Metadata
Title
Overuse of follow-up chest computed tomography in patients with incidentally identified nodules suspicious for lung cancer
Authors
Ran Guo
Yang Zhang
Zelin Ma
Chaoqiang Deng
Fangqiu Fu
Hong Hu
Yihua Sun
Haiquan Chen
Publication date
01-05-2022
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 5/2022
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-021-03692-6

Other articles of this Issue 5/2022

Journal of Cancer Research and Clinical Oncology 5/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine